These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 19222740)

  • 1. Should dialysate calcium concentration be standardised or individualised?
    Lindley EJ
    J Ren Care; 2009 Mar; 35 Suppl 1():101-6. PubMed ID: 19222740
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Calcium balance in dialysis is best managed by adjusting dialysate calcium guided by kinetic modeling of the interrelationship between calcium intake, dose of vitamin D analogues and the dialysate calcium concentration.
    Gotch F; Levin NW; Kotanko P
    Blood Purif; 2010; 29(2):163-76. PubMed ID: 20093823
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Review of dialysate calcium concentration in hemodialysis.
    Toussaint N; Cooney P; Kerr PG
    Hemodial Int; 2006 Oct; 10(4):326-37. PubMed ID: 17014507
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of treatment with 1.25 and 1.75 mmol/l calcium dialysate on bone mineral density in haemodialysis patients.
    Van der Niepen P; Sennesael J; Louis O; Verbeelen D
    Nephrol Dial Transplant; 1995 Dec; 10(12):2253-8. PubMed ID: 8808221
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Consequences of the implementation of K/DOQI Clinical Practice Guidelines for Bone Metabolism and Disease in Chronic Kidney Disease in a population of patients on chronic hemodialysis.
    Arenas MD; Alvarez-Ude F; Torregrosa V; Gil MT; Carretón MA; Moledous A; Nuñez C; Devesa R; Albiach B
    J Nephrol; 2007; 20(4):453-61. PubMed ID: 17879212
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Reversal of adynamic bone disease by lowering of dialysate calcium.
    Haris A; Sherrard DJ; Hercz G
    Kidney Int; 2006 Sep; 70(5):931-7. PubMed ID: 16837920
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Application of NKF-K/DOQI Clinical Practice Guidelines for Bone Metabolism and Disease: changes of clinical practices and their effects on outcomes and quality standards in three haemodialysis units.
    Arenas MD; Alvarez-Ude F; Gil MT; Soriano A; Egea JJ; Millán I; Amoedo ML; Muray S; Carretón MA
    Nephrol Dial Transplant; 2006 Jun; 21(6):1663-8. PubMed ID: 16464885
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Calcium mass balances during standard bicarbonate hemodialysis and long-hour slow-flow bicarbonate hemodialysis.
    Basile C; Libutti P; Di Turo AL; Tundo S; Maselli P; Casucci F; Losurdo N; Teutonico A; Vernaglione L; Lomonte C
    J Nephrol; 2011; 24(6):742-8. PubMed ID: 21360470
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Low calcium (1.25 mmol/L) dialysate can normalize relative hypoparathyroidism in CAPD patients with low bone turnover.
    Shigematsu T; Kawaguchi Y; Kubo H; Nakayama M; Kato N; Yamamoto H; Osaka N; Hayakawa H; Ogawa A; Sakai O
    Adv Perit Dial; 1996; 12():250-6. PubMed ID: 8865914
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Nocturnal but not short hours quotidian hemodialysis requires an elevated dialysate calcium concentration.
    Al-Hejaili F; Kortas C; Leitch R; Heidenheim AP; Clement L; Nesrallah G; Lindsay RM
    J Am Soc Nephrol; 2003 Sep; 14(9):2322-8. PubMed ID: 12937309
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Calcium kinetics and the long-term effects of lowering dialysate calcium concentration.
    Argilés A; Kerr PG; Canaud B; Flavier JL; Mion C
    Kidney Int; 1993 Mar; 43(3):630-40. PubMed ID: 8455362
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Calcium exposure and removal in chronic hemodialysis patients.
    Sigrist M; McIntyre CW
    J Ren Nutr; 2006 Jan; 16(1):41-6. PubMed ID: 16414440
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Calcium balance in haemodialysis--do not lower the dialysate calcium concentration too much (con part).
    Drüeke TB; Touam M
    Nephrol Dial Transplant; 2009 Oct; 24(10):2990-3. PubMed ID: 19666667
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Changes in mineral metabolism in stage 3, 4, and 5 chronic kidney disease (not on dialysis)].
    Lorenzo Sellares V; Torregrosa V
    Nefrologia; 2008; 28 Suppl 3():67-78. PubMed ID: 19018742
    [TBL] [Abstract][Full Text] [Related]  

  • 15. High-normal calcium (1.35 mmol/l) dialysate in patients on CAPD: efficient and safe long-term control of plasma calcium, phosphate, and parathyroid hormone.
    Bro S; Brandi L; Olgaard K
    Nephrol Dial Transplant; 1996 Aug; 11(8):1586-91. PubMed ID: 8856216
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Achieving K/DOQI laboratory target values for bone and mineral metabolism: an uphill battle.
    Al Aly Z; González EA; Martin KJ; Gellens ME
    Am J Nephrol; 2004; 24(4):422-6. PubMed ID: 15308874
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mineral and bone disorders in patients on dialysis: physiology and clinical consequences.
    McCarley PB; Arjomand M
    Nephrol Nurs J; 2008; 35(1):59-64. PubMed ID: 18372764
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Different routes bridging calcium in Japanese hemodialysis patients.
    Hamano T; Fujii N; Ito T; Imai E
    Ther Apher Dial; 2005 Feb; 9(1):32-8. PubMed ID: 15828903
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Reappraisal of 2003 NKF-K/DOQI guidelines for management of hyperparathyroidism in chronic kidney disease patients.
    Monge M; Shahapuni I; Oprisiu R; El Esper N; Morinière P; Massy Z; Choukroun G; Fournier A
    Nat Clin Pract Nephrol; 2006 Jun; 2(6):326-36. PubMed ID: 16932454
    [TBL] [Abstract][Full Text] [Related]  

  • 20. 1alpha(OH)D3 One-alpha-hydroxy-cholecalciferol--an active vitamin D analog. Clinical studies on prophylaxis and treatment of secondary hyperparathyroidism in uremic patients on chronic dialysis.
    Brandi L
    Dan Med Bull; 2008 Nov; 55(4):186-210. PubMed ID: 19232159
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.